Company: ZCARW
Filing Date: 2025-03-04
Form Type: S-1
Source: 0001213900-25-020176
Chunk: 98

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-04
Form: S-1
Chunk 98
---
 issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents (as such term is defined in the November Securities Purchase Agreement) or (b) file any registration statement, without the consent of a majority-in-interest of the purchasers, until 90 days after the later of (x) the earlier of (i) the date that the shares of Common Stock and the shares of Common Stock underlying the Pre-Funded Warrants on the Closing Date, and the maximum number of shares of Common Stock issuable under the Series B Warrants have become registered pursuant to an effective resale registration statement (the “November Offering Resale Registration Statement” and such date, the November Offering Resale Registration Effective Date”) and (ii) the date the securities can be sold pursuant to Rule 144 of the Securities Act, or (y) the date that the Company obtains the Stockholder Approval (described below) (the “Release Date”). The November Offering Resale Registration date occurred on December 13, 2024.The Company has also agreed not to conduct any variable rate transactions, without the consent of a majority-in-interest of the purchasers, for a period of six months after the Closing Date. Also, pursuant to the terms of the November Securities Purchase Agreement, the Company is required to hold a special meeting of stockholders (which may also be at the annual meeting of stockholders) at the earliest practicable date after the issuance date, but in no event later than 60 days after the Closing Date for the purpose of obtaining stockholder approval (“Stockholder Approval”) for the exercisability of the November Series A Warrants and the November Series B Warrants and for certain of the provisions included therein, including, adjustments to the exercise price and number of shares issuable upon exercise of the November Series A Warrants following a Dilutive Issuance (as defined in “ Description of Securities”) or Share Combination Event (as defined in “ Description of Securities”) or a reset adjustment under the November Series A Warrants (as described in “ Description of Securities”) and a reset adjustment under the November Series B Warrants (as described in “ Description of Securities”). Stockholder Approval was obtained at a Special Meeting of Stockholders on February 18, 2024, and, as a result, the exercise price of the November Series A Warrants was reduced to $0.806 per share and the number of shares available for exercise under the Series A Warrants was correspondingly increased so that the aggregate exercise price of the Series A Warrants remained